UnitedHealth Group Incorporated $UNH Shares Sold by Qtron Investments LLC

Key Points

• Qtron Investments LLC has reduced its holdings in UnitedHealth Group by 13.2%, selling 1,423 shares and now owning 9,380 shares valued at approximately $4.91 million.
• UnitedHealth Group reported earnings per share (EPS) of $4.08 for the last quarter, falling short of the consensus estimate of $4.45, with year-over-year revenue growth of 12.9%.
• Recently, the company declared a quarterly dividend of $2.21 per share, resulting in an annualized dividend yield of 2.9%.

Qtron Investments LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,380 shares of the healthcare conglomerate's stock after selling 1,423 shares during the period. UnitedHealth Group accounts for about 0.7% of Qtron Investments LLC's portfolio, making the stock its 20th biggest holding. Qtron Investments LLC's holdings in UnitedHealth Group were worth $4,913,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Northern Trust Corp lifted its position in shares of UnitedHealth Group by 12.5% in the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after buying an additional 1,058,488 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after buying an additional 2,301,010 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of UnitedHealth Group by 2.5% in the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock valued at $4,257,131,000 after purchasing an additional 196,696 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Down 1.5%

Shares of UnitedHealth Group stock traded down $4.72 during trading on Tuesday, hitting $303.77. 22,226,972 shares of the stock traded hands, compared to its average volume of 23,411,996. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock's fifty day simple moving average is $289.03 and its 200 day simple moving average is $393.55. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The firm has a market cap of $275.12 billion, a P/E ratio of 13.16, a price-to-earnings-growth ratio of 1.99 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is 38.30%.

Analyst Upgrades and Downgrades

UNH has been the subject of several research reports. HSBC reiterated a "reduce" rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Baird R W lowered UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Truist Financial dropped their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research note on Wednesday, July 16th. Finally, Oppenheimer cut their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $367.71.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.